🌅 Pre-Market Briefing — 2026-06-23

Source: finviz Elite (headless export) · Filter: mktcap ≥ $2B · price ≥ $5 · |gap| ≥ 4% · catalyst judgment by Opus · for Frank
Scanned 2,056 ≥$2B
121 up / 141 down
4 EP · 6 SIP · 10 Bounce (shown)
11 headline-mismatch
★ MAGNA hits: 4

Today's read

Semiconductors are broadly bid (UMC, SMCI, CRDO, VICR, TSEM, COHR) and biotech is active but mixed — a few real Phase readouts (DFTX, SYRE, KYMR) buried among governance / conference / grant filler. Two M&A targets gap hard but are capped at the deal price (APGE, ACA). The down side is concentrated in the SpaceX / space complex (post-IPO unwind) and gold miners (AGI guidance cut). Watch out: a large share of finviz's inline headlines do not explain the move — those are flagged MISMATCH and need a real-catalyst pull before you trust them.
⚠️ Facts + flags only — no buy/sell. EP/SIP/Bounce classifies the catalyst; the MAGNA list is a number-driven screen, not a pick. Sizing, entry & the trade are the trader's call.

★ MAGNA Top-2 — massive earnings/sales acceleration + low institutional ownership

Screen result, confirm the catalyst — not a buy recommendation.
SMCI
EPS Q/Q +314% · Sales +123% · Inst-Own 57% · RVOL 2.5 · SF 13%
Real AI-platform catalyst (EP). Strongest accel-plus-catalyst combo on the board. (Inst-own is only moderate, so not a pure 'neglect' name.)
UMC
EPS Q/Q +116% · Inst-Own 7% · gap +14% · semis bid
The truest 'massive accel + low neglect' fit — but the catalyst is a sector theme, so confirm a real single-name driver before leaning in.
⚠️ PLBL shows the rawest MAGNA numbers (EPS Q/Q +329%, inst-own 0.9%, 6.4M float, RVOL 8.4) but NO catalyst was found — pull the real driver before trusting it. CRDO also screens (EPS +337% / Sales +157%) but inst-own is 75%, so it fails the 'low neglect' leg.

⭐ Watchlist always shown, regardless of move

← swipe table →
TickerVerdictGapMkt CapFlagNews / Read
SMCIEP+15.7%$22.9BSQUEEZE
Dell/Super Micro AI-platform deal; EPS +314%, short float 13% = squeeze fuel. Uncapped, cleanest watchlist name today.
MUSIP+6.8%$1.37TCLEAN
Memory/semis strength (WSJ: 'memory price surge'). Sector-driven; ATR ~$80 so size for range.
ABBV+6.2%$406BACQUIRER
The BUYER of Apogee ($10.9B) — not capped. Reaction = market's verdict on the deal (mildly positive).
PLTR-7.0%$286BMISMATCH
Headline is POSITIVE (secures NGC2 role) yet stock is DOWN 7% — likely high-multiple selloff. Investigate before fading the drop.
AGI-11.8%$13.5BSTRUCTURAL
Real cause = Q2 production guidance cut (operational). RVOL 4.8 = real selling. A guide-down is structural — NOT a clean fade.
AAPL / NVDA / AMDflatNEUTRAL
No actionable pre-market move (−0.3% / −1.0% / +2.6%); shown for completeness.

🎯 Potential — Core ≥ $2B EP/SIP/Bounce · Catalyst · Binding·Scale · MAGNA · tradeability · veto flag · read

← swipe table → (ticker stays pinned)
TkrVerdictCatalystWhy (B·S)GapRVOLSF%ATRMktCapInst%EPS q/qSales q/qFlagNews / Read
DFTXEPClinical / Regdata·transform.+49.8%10.59.0%2.34$4.0B70%-158%BINARY
Phase-3 psychedelic readout positive ('best-case'). Real EP catalyst, but the event is resolved and biotechs often raise into strength — watch for an offering.
APGEEPM&A (target)definitive·large+46.7%61.818.5%7.43$10.0B93%-12%CAPPED
Being acquired by AbbVie. The +47% is the stock repricing to the cash deal price — upside is pinned, no continuation. Frank's prompt would call this a roaring EP; it's dead money.
SMCIEPProduct / AIsigned·large+15.7%2.513.4%3.64$22.9B57%+314%+123%SQUEEZE
Dell & Super Micro committing to Nvidia's next AI platform — reputable partner, scale-relevant. EPS +314% / Sales +123% = massive acceleration; short float 13% adds squeeze fuel. Cleanest EP on the board.
PAYPEPM&A (acquirer)definitive·large+10.9%1.70.5%1.04$9.2B4%ACQUIRER
PayPay buying a majority stake in T&D Financial Life — it's the BUYER, so NOT capped (unlike a target). Inst-own 4% = under-owned.
SYRESIPClinical datadata·early+13.6%2.316.3%5.17$8.7B87%-47%BINARY
Part-A induction results for SPY002 (anti-TL1A). Early-stage data — real but not yet transformational; binary + dilution-watch.
VIAVSIPProductsigned·increment.+12.2%1.35.2%4.42$13.0B96%-70%+43%CLEAN
PCIe 6.0 platform earns PCI-SIG Gold cert — a real product win but incremental, not trajectory-changing. RVOL only 1.3 = thin participation so far.
CRDOSIPAnalystopinion·—+11.3%1.26.1%24.7$56B75%+337%+157%ANALYST
Evercore says the Street is 40% too low. The catalyst is an opinion (soft), but fundamentals are MAGNA-grade: EPS +337% / Sales +157%. Inst-own 75% (not neglected).
KYMRSIPClinical datadata·early+10.0%4.914.2%4.55$8.2B105%+13%+56%BINARY
Phase-1 data for KT-621 in healthy Japanese adults. Early and binary; meaningful RVOL 4.9.
UMCSIPSector themenone·sector+14.2%1.81.0%1.53$69B7%+116%+10%THEME
Riding the semis bid, not a single-name catalyst. But the MAGNA fit is real: EPS +116% with inst-own just 7% (true low-neglect). Confirm a real driver before leaning on the gap.
VICRSIPVague / themenone·—+10.3%1.06.3%26.6$17B47%+684%+20%MISMATCH
'Gaining on search for AI power' is vague/promotional. EPS +684% is eye-popping and the float is tiny (25M), but the catalyst is soft — treat as momentum, not a clean EP.
TEBounceGovernancefiller·—+11.2%1.718.3%1.21$2.9B65%+30%+232%MISMATCH
Headline is 'annual meeting results' — governance filler, doesn't explain +11%. (Sales +232% is notable, though — worth a real-catalyst pull.)
BWINBounceRumorrumor·—+16.2%3.012.9%1.52$2.3B93%-88%+29%MISMATCH
Shown headline is a generic 'top calls' blurb. The real driver is a take-private rumor — unconfirmed; pull the real catalyst before acting.
BHVNBounceMismatchfiller·—+14.2%2.320.1%1.04$2.3B92%+59%MISMATCH
Headline is about Pfizer's CFO — nothing to do with Biohaven. +14% is unexplained; needs a real-catalyst pull. Short float 20% if it turns out to be real.
ORKABounceConferencefiller·—+18.0%2.712.6%4.98$5.1B76%-14%MISMATCH
'To present at a conference' is not a catalyst. +18% is unexplained — investigate before trusting.
KLRABounceIPO debutn/a·—+15.0%0.83.0%1.71$3.0B12%MISMATCH
Kardigan Nasdaq-debut pop — IPO dynamics, no float history, RVOL 0.8. A different animal from an EP.
TSEMBounceSympathynone·sector+10.5%1.12.8%21.8$35B74%+60%+15%MISMATCH
Headline is about Marvell — Tower Semi is moving in semis sympathy, not on its own news.
SMTCBounceIndex/symp.none·—+10.4%1.06.9%13.2$16B+25%+16%MISMATCH
Headline = Marvell/Flex S&P 500 inclusion. Semtech is sympathy, not the named story.
ERASBounceBoilerplatefiller·—+10.3%1.317.1%1.16$4.7B63%-452%MISMATCH
'Sued for securities violations — contact law firm' is boilerplate solicitation; it doesn't drive a +10% UP move. The real driver is elsewhere.
CHRNBounceExec hirefiller·—+10.0%3.30.3%2.73$3.7B0.6%-19%-37%MISMATCH
CTO / CPO appointments — not a catalyst. Inst-own 0.6% (ultra-low) so it moves easily on thin news; RVOL 3.3 says someone is playing it.
PLBLBounceNonenone·—+9.6%8.40.4%1.11$3.1B0.9%+329%NEWS-NONE
No headline at all, yet RVOL 8.4 with EPS +329%, inst-own 0.9% and a 6.4M float — the rawest MAGNA numbers on the board but ZERO catalyst. Pull the real driver before touching.
VerdictEP = binding + transformational catalyst · SIP = real news but soft / partial / incremental · Bounce = minor / rumor / mismatch / no catalyst.   Why (B·S) = Binding (signed vs rumor) · Scale (trajectory-changing vs routine).   Flag vetoes downgrade false-EPs: CAPPED = pinned to a deal price (dead money) · MISMATCH = headline doesn't explain the move, pull the real catalyst · BINARY = event resolved + biotech dilution-watch · ACQUIRER = buyer, not capped.

🔻 Down — Fade Candidates / Shorts ≥$2B · this is where the "fade the overreaction" calls live

← swipe table →
TickerGapMkt CapFlagNews / Read
SPCX-16.4%$2.04TSECTOR
Space leader continuing its post-IPO unwind; dragging the whole space complex with it.
AGI-11.8%$13.5BSTRUCTURAL
Q2 production guidance cut (operational) plus a soft gold tape. Structural, not a clean fade.
GFI-10.3%$31BSECTOR
Gold miners broadly weak — a sector move, not company-specific.
RIVN-8.6%$19BRUMOR
'Reportedly' hit with a class-action over Gen-1 claims — unconfirmed, headline-risk symmetric (a denial round-trips it).
NN-9.1%$2.3BMISLABEL-AVOIDED
'Redemption of convertible notes' actually REDUCES dilution (regex would mislabel it). The down move isn't explained by it — investigate.
VCX / RDW / ASTS / VOYG-8 to -11%SECTOR
SpaceX / space complex broadly down on the post-IPO unwind. ASTS short float 30% = volatile both ways.

🚀 Small-Cap Surge $300M–$2B · RVOL ≥ 3 · gap ≥ 8% · names with a shot at $2B

← swipe table →
TickerGapMkt CapFlagNews / Read
HQ+20.0%$1.2BTHEME
Quantum theme with a government angle ('governments worldwide buying in'). RVOL 4.8.
NVCT+19.6%$439MCLEAN
Licensing deal with Haisco for two clinical-stage assets — binding, named partner. The cleanest small-cap catalyst here.
SSTK+18.8%$577MSYMPATHY
Moving with Getty (+145% on its OpenAI deal) — they're the merger partner. Sympathy, not its own news.
WYFI+16.3%$1.7BSQUEEZE
Short float 35% = prime squeeze candidate; the shown headline (a $20M loan PR) is unrelated to the move.
RGNX+16.3%$469MBINARY
Gene-therapy / FDA progress; RVOL 6.8. Binary biotech — confirm the specifics.
MLTX+15.4%$1.6BMISMATCH
'Best day in 6 months' — momentum, no catalyst stated in the headline. Pull the real driver.

📊 Sector Tilt is today a name-day or a sector-day?

Semiconductors / AI HW
UP
UMC · TSEM · SMTC · AXTI · COHR · VICR · CRDO · VIAV · SMCI · MU
Biotech
UP
DFTX · SYRE · KYMR · NVCT · RGNX (real data/deals) + lots of filler
Gold miners
DOWN
AGI · GFI
Space / SpaceX complex
DOWN
SPCX · VCX · RDW · ASTS · VOYG (post-IPO unwind)